Exact Mass: 407.98023700000005
Exact Mass Matches: 407.98023700000005
Found 89 metabolites which its exact mass value is equals to given mass value 407.98023700000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Antibiotic MM4550
C13H16N2O9S2 (408.02972059999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
6-Hydroxy-5-[(4-sulfophenyl)azo]-2-naphthalenesulfonic acid
Yellow food dye used in cereals, bakery products, sweets, snack foods, ice cream, drinks and canned fish.
(6E,8E,12E)-3-methylene-4-oxo-7,11-dimethyl-(10S*,11R*)-dichloro-13-bromotrideca-6,8,12-trienoic acid|Polyhalogenated homosesquiterpenic fatty acid A
(3Z,11Z,7S*,9R*,10R*)-6-chloro-9,13-dibromo-7:10-epoxypentadeca-3,11-dien-1-yne
13-bromo-10R,11R-dichloro-7,11-dimethyl-3-methylene-4-oxo-6E,8E,12E-tridecatrienoic acid
13-bromo-10S,11R-dichloro-7,11-dimethyl-3-methylene-4-oxo-6E,8E,12E-tridecatrienoic acid
2,5-BIS(3-(N,N-DIETHYLAMINO)-1-OXAPROPYL
C14H22Br2N2O2 (408.00479119999994)
(6-PYRROLIDIN-1-YLPYRID-2-YL)METHANOL
C10H12N6O6S3 (407.99804520000004)
Xanthosine 5-monophosphate sodium salt
C10H11N4Na2O9P (408.00590460000006)
Xanthosine 5'-monophosphate sodium salt (5'-Xanthylic acid sodium salt) is an intermediate in purine metabolism. Xanthosine 5'-monophosphate sodium salt can be used for genetic code, nucleic acid structure, and DNA, RNA and protein synthesis research[1].
ethyl 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylate
2,2-bis(3,5-difluoro-4-hydroxyphenyl)hexafluoropropane
3-Ethyl-2-(2-(phenylamino)vinyl)benzo[d]thiazol-3-ium iodide
C17H17IN2S (408.01571520000005)
Tranxene
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
(S)-2-Benzothiazolyl (Z)-2-(2-aminothiazole-4-yl)-2-methoxycarbonylmethoxyiminothioacetate
dipotassium 2-(6-oxido-3-oxoxanthen-9-yl)benzoate
C20H10K2O5 (407.98023700000005)
2-(4-Fluorophenyl)-5-[(5-iodo-2-Methylphenyl)methyl]thiophene
3-{[5-deoxy-5-(dimethylarsoryl)-
C10H21AsO10S (408.00713460000003)
N-[1-[(3,4-dichlorophenyl)methyl]-6-oxo-3-pyridinyl]benzenesulfonamide
6-Hydroxy-5-((4-sulphophenyl)azo)naphthalene-2-sulphonic acid
D000074385 - Food Ingredients > D005503 - Food Additives > D005505 - Food Coloring Agents D004396 - Coloring Agents
2,4-dichloro-5-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide
2-(4-chlorophenoxy)-N-[[4-(3-chlorophenyl)-5-sulfanylidene-1H-1,2,4-triazol-3-yl]methyl]acetamide
1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridin-1-ium-3,5-dicarbothioate
(11-Methoxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaen-14-yl) hydrogen sulate
(Z)-3,4,4,5,5,6,6,7,7,8,8,9,9,9-tetradecafluoronon-2-enoic acid
dipotassium clorazepate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
dADP(3-)
A 2-deoxyribonucleoside 5-diphosphate obtained by deprotonation of the diphosphate OH groups of 2-deoxyadenosine 5-diphosphate (dADP); major species at pH 7.3.
10074-A4
10074-A4 is a c-Myc inhibitor. 10074-A4 could bind to c-Myc370-409 at different sites along the peptide chain. 10074-A4 has anticancer effects[1][2].
3,8-dibromo-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-9-ene-4,11-diol
C15H22Br2O3 (407.99355819999994)
4,8-dibromo-9-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undec-3-en-2-one
(5r)-5-[(1s,2e)-10,10-dibromo-1-methoxydeca-2,9-dien-1-yl]oxolan-2-one
C15H22Br2O3 (407.99355819999994)
(11e)-16-bromo-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione
(5r)-5-[(1e,3s)-10,10-dibromo-3-methoxydeca-1,9-dien-1-yl]oxolan-2-one
C15H22Br2O3 (407.99355819999994)
(5r,6r)-3-[(r)-(1e)-2-[(1-hydroxyethylidene)amino]ethenesulfinyl]-7-oxo-6-[(1s)-1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O9S2 (408.02972059999996)
(2r,3r,5s,6s)-3-bromo-2-[(2e)-3-bromopent-2-en-1-yl]-5-chloro-6-[(2e)-pent-2-en-4-yn-1-yl]oxane
5-(10,10-dibromo-3-methoxydeca-1,9-dien-1-yl)oxolan-2-one
C15H22Br2O3 (407.99355819999994)
(2r,3r,5s,6s)-3-bromo-2-[(2z)-3-bromopent-2-en-1-yl]-5-chloro-6-[(2e)-pent-2-en-4-yn-1-yl]oxane
3,8-dibromo-4-chloro-4,12,12-trimethyl-11-methylidene-7-oxatricyclo[6.3.1.0¹,⁶]dodec-9-ene
(5s)-5-[(1r,2e)-10,10-dibromo-1-methoxydeca-2,9-dien-1-yl]oxolan-2-one
C15H22Br2O3 (407.99355819999994)
(2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropoxysulfonic acid
C10H21AsO10S (408.00713460000003)
3-{2-[(1-hydroxyethylidene)amino]ethenesulfinyl}-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O9S2 (408.02972059999996)
(4r,6r,8r,9z,11e)-16-bromo-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.0⁶,⁸]nonadeca-1(19),9,11,15,17-pentaene-2,13-dione
(6e,8e,10s,11r,12e)-13-bromo-10,11-dichloro-7,11-dimethyl-3-methylidene-4-oxotrideca-6,8,12-trienoic acid
(2r,3r,5s)-3-bromo-2-[(1z)-3-bromopent-1-en-1-yl]-5-[(3z)-1-chlorohex-3-en-5-yn-1-yl]oxolane
(2r,3r,5r,6s)-3-bromo-2-[(2e)-3-bromopent-2-en-1-yl]-5-chloro-6-[(2z)-pent-2-en-4-yn-1-yl]oxane
(5s)-5-[(1e,3s)-10,10-dibromo-3-methoxydeca-1,9-dien-1-yl]oxolan-2-one
C15H22Br2O3 (407.99355819999994)
(6e,8e,10r,11r,12e)-13-bromo-10,11-dichloro-7,11-dimethyl-3-methylidene-4-oxotrideca-6,8,12-trienoic acid
(5r)-5-[(1e,3r)-10,10-dibromo-3-methoxydeca-1,9-dien-1-yl]oxolan-2-one
C15H22Br2O3 (407.99355819999994)
(6s,8s,9s)-4,8-dibromo-9-chloro-5,5,9-trimethyl-1-methylidenespiro[5.5]undec-3-en-2-one
3-bromo-2-(3-bromopent-1-en-1-yl)-5-(1-chlorohex-3-en-5-yn-1-yl)oxolane
3-[(1e)-2-[(1-hydroxyethylidene)amino]ethenesulfinyl]-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C13H16N2O9S2 (408.02972059999996)
(2s,3r,5s,6r)-3-bromo-2-[(2e)-3-bromopent-2-en-1-yl]-5-chloro-6-[(2e)-pent-2-en-4-yn-1-yl]oxane
(1r,3s,4s,6s,8r,11r)-3,8-dibromo-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodec-9-ene-4,11-diol
C15H22Br2O3 (407.99355819999994)
5-(10,10-dibromo-1-methoxydeca-2,9-dien-1-yl)oxolan-2-one
C15H22Br2O3 (407.99355819999994)
(2s)-2-[(1r)-11,11-dibromo-1-methoxyundeca-2,10-dien-1-yl]oxolane
3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropoxysulfonic acid
C10H21AsO10S (408.00713460000003)
3-bromo-2-(3-bromopent-2-en-1-yl)-5-chloro-6-(pent-2-en-4-yn-1-yl)oxane
(1s,3r,4r,6r,8s)-3,8-dibromo-4-chloro-4,12,12-trimethyl-11-methylidene-7-oxatricyclo[6.3.1.0¹,⁶]dodec-9-ene
(2r,3r,5s)-3-bromo-2-[(1z,3r)-3-bromopent-1-en-1-yl]-5-[(1r,3z)-1-chlorohex-3-en-5-yn-1-yl]oxolane
13-bromo-10,11-dichloro-7,11-dimethyl-3-methylidene-4-oxotrideca-6,8,12-trienoic acid
(5s)-5-[(1e,3r)-10,10-dibromo-3-methoxydeca-1,9-dien-1-yl]oxolan-2-one
C15H22Br2O3 (407.99355819999994)